ReviewGastroenterology2008
Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.
Michael Camilleri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it